@evelynlinda9.bsky.social Thanks for your feedback! I am glad you find our analysis insightful. Biologicals are a complementary solution to traditional inputs, so a hybrid model is expected, in which large incumbents "outsource" part of their R&D and exploration strategies to smaller firms.
28.08.2025 00:48 — 👍 0 🔁 0 💬 0 📌 0
From a business perspective, our study shows that incumbent input firms are facing a transition that challenges their business-as-usual scenario. These companies are exploring to find the right balance between their core business and these new products based on living organisms and natural extracts.
23.04.2025 19:08 — 👍 1 🔁 0 💬 2 📌 0
#NewPaper
#Biological inputs are becoming a valuable complement to chemical crop protection and synthetic fertilizers. How are traditional #aginput incumbents reconfiguring to adapt and incorporate these solutions into their product portfolios? @jsellare.bsky.social
doi.org/10.1002/bse....
Can #ValueChains become drivers of sustainable innovation in a #BioeconomyUpgrading? We explore this interplay between technological #Innovation, #ValueChains and social #Sustainability with @jsellare.bsky.social in our recently published paper in BS&D onlinelibrary.wiley.com/doi/10.1002/...
13.03.2025 10:25 — 👍 4 🔁 2 💬 0 📌 0
To what extent can value chains (VC) be a catalyst to #bioeconomic transformations? Will businesses have to adapt to the emergence of new #bio-based tech? Who will benefit from these changes? @pmacclay.bsky.social & I address these Qs in our new paper 👇 🧵1/6
onlinelibrary.wiley.com/doi/10.1002/...
